ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Alkermes plc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$42.97+1.75 (+4.25%)
Close on Oct 19, 2026
- Market cap
- $7.45B
- P/E (TTM)
- 113.1
- Dividend yield
- –
Alkermes statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Alkermes | Industry median |
|---|---|---|
| Market Cap | $7.21B | $166.30M |
| Enterprise Value | $8.06B | $88.19M |
| PE Ratio | 113.08 | 20.44 |
| PS Ratio | 4.32 | 3.65 |
| PB Ratio | 3.99 | 2.03 |
| P/FCF Ratio | 32.52 | 17.44 |
| P/OCF Ratio | 28.70 | 12.98 |
Enterprise value
| Measure | Alkermes | Industry median |
|---|---|---|
| EV / Sales | 4.83 | 2.51 |
| EV / EBITDA | 45.03 | 14.65 |
| EV / EBIT | 68.70 | 19.00 |
| EV / FCF | 36.34 | 20.86 |
Income (trailing twelve months)
| Measure | Alkermes | Industry median |
|---|---|---|
| Revenue | $1.67B | $58.34M |
| Gross Profit | $1.41B | $105.94M |
| Operating Income | $117.26M | -$21.40M |
| Pretax Income | $97.32M | -$14.34M |
| Net Income | $66.12M | -$22.46M |
| EBITDA | $178.89M | -$16.91M |
| EPS (Diluted) | $0.38 | -$0.83 |
Margins
| Measure | Alkermes | Industry median |
|---|---|---|
| Gross Margin | 84.6% | 52.9% |
| Operating Margin | 7.03% | -44.0% |
| Pretax Margin | 5.84% | -13.3% |
| Profit Margin | 3.97% | -40.2% |
| EBITDA Margin | 10.7% | -30.2% |
| FCF Margin | 13.3% | -9.27% |
Returns
| Measure | Alkermes | Industry median |
|---|---|---|
| Return on Equity (ROE) | 3.85% | -53.2% |
| Return on Assets (ROA) | 1.99% | -40.9% |
| Return on Invested Capital (ROIC) | 4.88% | -32.4% |
| Return on Capital Employed (ROCE) | 3.14% | -38.1% |
Growth
| Measure | Alkermes | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 10.8% | 5.96% |
| Net Income Growth (YoY) | -81.0% | -35.2% |
| EPS Growth (YoY) | -81.7% | -26.2% |
| FCF Growth (YoY) | -53.8% | 2.34% |
| Revenue Growth (3Y CAGR) | 9.90% | 2.25% |
| Revenue Growth (5Y CAGR) | 7.28% | 6.48% |
Balance sheet
| Measure | Alkermes | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $656.58M | $61.43M |
| Total Debt | $1.50B | $118.52M |
| Net Cash (Debt) | -$846.53M | $15.35M |
| Net Cash Per Share | -$5.05 | $0.66 |
| Equity (Book Value) | $1.81B | $49.09M |
| Book Value Per Share | $10.78 | $1.37 |
| Tangible Book Value | -$547.18M | $23.52M |
| Working Capital | $860.82M | $76.81M |
Financial position
| Measure | Alkermes | Industry median |
|---|---|---|
| Current Ratio | 2.30 | 3.34 |
| Quick Ratio | 1.68 | 2.44 |
| Debt / Equity | 0.83 | 0.52 |
| Debt / EBITDA | 8.40 | 3.44 |
| Debt / FCF | 6.78 | 4.89 |
| Net Debt / EBITDA | 4.73 | 2.36 |
| Interest Coverage | 1.98 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Alkermes | Industry median |
|---|---|---|
| Operating Cash Flow | $251.18M | -$12.35M |
| Capital Expenditures | -$29.53M | -$1.08M |
| Free Cash Flow | $221.65M | -$20.22M |
| FCF Per Share | $1.32 | -$0.42 |
Efficiency
| Measure | Alkermes | Industry median |
|---|---|---|
| Asset Turnover | 0.50 | 0.39 |
| Inventory Turnover | 1.05 | 2.70 |
| Revenue Per Employee | $813.49K | $404.87K |
| Profits Per Employee | $32.26K | -$703.34K |
| Employee Count | 2,050 | 74 |
Dividends and yields
| Measure | Alkermes | Industry median |
|---|---|---|
| Earnings Yield | 0.92% | -23.3% |
| FCF Yield | 3.07% | -8.72% |
Shares
| Measure | Alkermes | Industry median |
|---|---|---|
| Shares Outstanding | 167,763,000 | 58,127,000 |
| Shares Change (YoY) | 1.12% | 10.9% |
| Shares Change (QoQ) | 0.65% | 0.54% |
| Float | 165,151,000 | 49,136,700 |
| Shares Held by Insiders | 1.56% | 11.6% |
Taxes
| Measure | Alkermes | Industry median |
|---|---|---|
| Income Tax | $31.20M | $79.87K |
| Effective Tax Rate | 32.1% | 20.6% |
Scores
| Measure | Alkermes | Industry median |
|---|---|---|
| Graham Number | $9.60 | $18.73 |
| Graham Upside | -77.7% | -45.1% |
| Altman Z-Score | 2.12 | -0.22 |
| Piotroski F-Score | 7 | 4 |
| Beneish M-Score | -3.29 | -2.62 |
Calculated by StockData from Alkermes's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.